Identification of polymorphisms associated with attenuation of Vif and Vpr in HIV-1 Elite Controllers
Suwellen Sardinha Dias de Azevedo, Fernanda Heloise Côrtes, Mariza G Morgado, Brenda Hoagland, Larissa M Villela, Beatriz Grinsztejn, Valdilea Gonçalvez Veloso, Gonzalo Bello

TL;DR
The study identifies genetic mutations in HIV-1 proteins Vif and Vpr that may help some individuals naturally control the virus without treatment.
Contribution
The paper reports specific polymorphisms and defects in Vif and Vpr genes among HIV-1 elite controllers that are linked to reduced viral fitness.
Findings
Certain ECs have proviral clones with stop codons and attenuating polymorphisms in Vif and Vpr.
Polymorphisms like Vpr-R77Q are commonly found in all proviral clones of some ECs.
Hypermutated sequences and insertions in Vif are observed in a subset of ECs.
Abstract
Elite controllers (ECs) are a rare subset of individuals who naturally suppress human immunodeficiency virus type 1 (HIV-1) replication in the absence of antiretroviral therapy. Specific polymorphisms in the accessory proteins Vif and Vpr have been associated with diminished viral fitness in vitro and are more frequently detected in ECs compared to other individuals infected with HIV-1. To assess the frequency of gross genetic defects or polymorphisms that may attenuate the function of the HIV-1 accessory proteins Vif and Vpr within the proviral quasispecies of ECs. We performed single-genome amplification (SGA) and sequence analysis of the proviral quasispecies of the accessory genes vif and vpr in samples obtained from eight ECs with over 10 years of suppressive viral control and no evidence of disease progression. In subjects EC11, EC38 and EC52, most proviral clones encode…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV Research and Treatment · HIV/AIDS drug development and treatment · Hepatitis C virus research
